LifeVantage 향후 성장

Future 기준 점검 2/6

LifeVantage은 연간 수입과 매출이 각각 17.6%와 4.3% 증가할 것으로 예상되고 EPS는 연간 16.3%만큼 증가할 것으로 예상됩니다.

핵심 정보

17.6%

이익 성장률

16.35%

EPS 성장률

Personal Products 이익 성장	32.8%
매출 성장률	4.3%
향후 자기자본이익률	n/a
애널리스트 커버리지	Low
마지막 업데이트	14 Nov 2025

최근 향후 성장 업데이트

LifeVantage Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Feb 07

Recent updates

Lacklustre Performance Is Driving LifeVantage Corporation's (NASDAQ:LFVN) 28% Price Drop

Nov 14

We Ran A Stock Scan For Earnings Growth And LifeVantage (NASDAQ:LFVN) Passed With Ease

Nov 04

It's Down 25% But LifeVantage Corporation (NASDAQ:LFVN) Could Be Riskier Than It Looks

Sep 30

LifeVantage (NASDAQ:LFVN) Will Pay A Dividend Of $0.045

Sep 05

The LifeVantage Advantage: High Retention, High Returns

Jul 21

Shareholders Can Be Confident That LifeVantage's (NASDAQ:LFVN) Earnings Are High Quality

May 13

What You Can Learn From LifeVantage Corporation's (NASDAQ:LFVN) P/E After Its 26% Share Price Crash

May 02

New Initiatives Will Drive MindBody GLP-1 System's Future Success

Feb 14 Expansion into international markets and enhanced supply chain capacity are expected to drive significant revenue growth and stabilize future sales.

LifeVantage (NASDAQ:LFVN) Will Pay A Dividend Of $0.04

Feb 09

LifeVantage Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Feb 07

Market Participants Recognise LifeVantage Corporation's (NASDAQ:LFVN) Earnings Pushing Shares 31% Higher

Dec 20

LifeVantage (NASDAQ:LFVN) Will Be Hoping To Turn Its Returns On Capital Around

Dec 16

LifeVantage's (NASDAQ:LFVN) Dividend Will Be $0.04

Nov 16

LifeVantage's (NASDAQ:LFVN) Dividend Will Be $0.04

Nov 02

Subdued Growth No Barrier To LifeVantage Corporation (NASDAQ:LFVN) With Shares Advancing 63%

Sep 29

We Think LifeVantage's (NASDAQ:LFVN) Solid Earnings Are Understated

Sep 05

LifeVantage Corporation (NASDAQ:LFVN) Stock Catapults 28% Though Its Price And Business Still Lag The Industry

Aug 15

Some Investors May Be Worried About LifeVantage's (NASDAQ:LFVN) Returns On Capital

Aug 02

Is There Now An Opportunity In LifeVantage Corporation (NASDAQ:LFVN)?

Jul 15

LifeVantage Corporation (NASDAQ:LFVN) Stock Catapults 28% Though Its Price And Business Still Lag The Industry

May 30

The Returns On Capital At LifeVantage (NASDAQ:LFVN) Don't Inspire Confidence

Apr 22

이익 및 매출 성장 예측

NasdaqCM:LFVN - 애널리스트 향후 추정치 및 과거 재무 데이터 (USD Millions)
날짜	매출	이익	자유현금흐름	영업현금흐름	평균 애널리스트 수
6/30/2028	257	16	N/A	N/A	1
6/30/2027	243	15	10	23	3
6/30/2026	228	12	6	21	3
9/30/2025	229	10	9	10	N/A
6/30/2025	229	10	11	12	N/A
3/31/2025	222	9	12	13	N/A
12/31/2024	212	7	13	14	N/A
9/30/2024	196	4	5	7	N/A
6/30/2024	200	3	10	12	N/A
3/31/2024	205	4	11	13	N/A
12/31/2023	211	3	11	14	N/A
9/30/2023	213	3	9	13	N/A
6/30/2023	213	3	4	7	N/A
3/31/2023	210	-1	3	6	N/A
12/31/2022	206	-1	1	3	N/A
9/30/2022	205	0	4	6	N/A
6/30/2022	206	3	6	8	N/A
3/31/2022	210	9	12	14	N/A
12/31/2021	212	10	13	16	N/A
9/30/2021	219	14	15	18	N/A
6/30/2021	220	13	13	16	N/A
3/31/2021	225	12	13	17	N/A
12/31/2020	229	12	15	17	N/A
9/30/2020	232	12	18	21	N/A
6/30/2020	233	12	16	18	N/A
3/31/2020	230	12	13	16	N/A
12/31/2019	230	12	13	17	N/A
9/30/2019	227	8	9	12	N/A
6/30/2019	226	7	N/A	18	N/A
3/31/2019	224	7	N/A	16	N/A
12/31/2018	218	6	N/A	16	N/A
9/30/2018	210	6	N/A	13	N/A
6/30/2018	203	6	N/A	13	N/A
3/31/2018	200	3	N/A	10	N/A
12/31/2017	194	1	N/A	6	N/A
9/30/2017	194	1	N/A	6	N/A
6/30/2017	199	2	N/A	7	N/A
3/31/2017	202	4	N/A	4	N/A
12/31/2016	213	5	N/A	3	N/A
9/30/2016	216	6	N/A	6	N/A
6/30/2016	207	6	N/A	6	N/A
3/31/2016	199	4	N/A	10	N/A
12/31/2015	188	3	N/A	14	N/A
9/30/2015	184	3	N/A	11	N/A
6/30/2015	190	7	N/A	13	N/A
3/31/2015	201	9	N/A	11	N/A
12/31/2014	211	11	N/A	13	N/A

애널리스트 향후 성장 전망

수입 대 저축률: LFVN 의 연간 예상 수익 증가율(17.6%)이 saving rate(3.3%)보다 높습니다.

수익 vs 시장: LFVN 의 연간 수익(17.6%)이 US 시장(16.2%)보다 빠르게 성장할 것으로 예상됩니다.

고성장 수익: LFVN 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.

수익 대 시장: LFVN 의 수익(연간 4.3%)이 US 시장(연간 10.7%)보다 느리게 성장할 것으로 예상됩니다.

고성장 매출: LFVN 의 수익(연간 4.3%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.

주당순이익 성장 예측

향후 자기자본이익률

미래 ROE: LFVN의 자본 수익률이 3년 후 높을 것으로 예상되는지 판단하기에 데이터가 부족합니다.

성장 기업 찾아보기

기업 분석 및 재무 데이터 상태

데이터	최종 업데이트 (UTC 시간)
기업 분석	2025/12/26 09:49
종가	2025/12/26 00:00
수익	2025/09/30
연간 수익	2025/06/30

데이터 소스

당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.

패키지	데이터	기간	미국 소스 예시 ^*
기업 재무제표	10년	손익계산서 현금흐름표 대차대조표	SEC 양식 10-K SEC 양식 10-Q
분석가 컨센서스 추정치	+3년	재무 예측 분석가 목표주가	분석가 리서치 보고서 Blue Matrix
시장 가격	30년	주가 배당, 분할 및 기타 조치	ICE 시장 데이터 SEC 양식 S-1
지분 구조	10년	주요 주주 내부자 거래	SEC 양식 4 SEC 양식 13D
경영진	10년	리더십 팀 이사회	SEC 양식 10-K SEC 양식 DEF 14A
주요 개발	10년	회사 공시	SEC 양식 8-K

^* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.

별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.

분석 모델 및 스노우플레이크

이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 Github 페이지에서 확인할 수 있으며, 보고서 활용 방법에 대한 가이드와 Youtube 튜토리얼도 제공합니다.

Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.

산업 및 섹터 지표

산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.

분석가 소스

LifeVantage Corporation는 5명의 분석가가 다루고 있습니다. 이 중 3명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.

분석가	기관
Ilya Zubkov	Freedom Broker
Mitchell Pinheiro	Imperial Capital
Ryan Meyers	Lake Street Capital Markets, LLC

LifeVantage 향후 성장

Future 기준 점검 2/6

핵심 정보

최근 향후 성장 업데이트

Consensus EPS estimates fall by 26%

LifeVantage Corporation Provides Earnings Guidance for the Fiscal Year 2026

Price target decreased by 27% to US$18.00

Consensus EPS estimates fall by 20%

LifeVantage Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

LifeVantage Corporation Raises Revenue Guidance for the Fiscal Year 2025

Recent updates

Upcoming dividend of US$0.045 per share

Independent Director recently sold US$81k worth of stock

New major risk - Revenue and earnings growth

Lacklustre Performance Is Driving LifeVantage Corporation's (NASDAQ:LFVN) 28% Price Drop

New Study Finds LifeVantage Corporation's P84 Positively Impacts Gut Peptide Production, Activating Key Elements for Comprehensive Gut Health

Independent Director recently sold US$250k worth of stock

Independent Director notifies of intention to sell stock

First quarter dividend of US$0.045 announced

First quarter 2026 earnings: EPS and revenues miss analyst expectations

LifeVantage Corporation Declares Cash Dividend, Payable on December 15, 2025

Investor sentiment deteriorates as stock falls 18%

We Ran A Stock Scan For Earnings Growth And LifeVantage (NASDAQ:LFVN) Passed With Ease

LifeVantage Corporation to Report Q1, 2026 Results on Nov 04, 2025

It's Down 25% But LifeVantage Corporation (NASDAQ:LFVN) Could Be Riskier Than It Looks

LifeVantage Corporation, Annual General Meeting, Nov 06, 2025

New minor risk - Insider selling

Consensus EPS estimates fall by 26%

Full year 2025 earnings: EPS and revenues miss analyst expectations

President exercised options and sold US$1.3m worth of stock

LifeVantage (NASDAQ:LFVN) Will Pay A Dividend Of $0.045

LifeVantage Corporation Provides Earnings Guidance for the Fiscal Year 2026

Third quarter dividend of US$0.045 announced

LifeVantage Corporation Declares Quarterly Cash Dividend on Common Stock, Payable on September 16, 2025

LifeVantage Corporation to Report Q4, 2025 Results on Sep 04, 2025

LifeVantage Corporation Announces Expanded Human Clinical Study for MindBody GLP-1 System

The LifeVantage Advantage: High Retention, High Returns

Price target decreased by 27% to US$18.00

Upcoming dividend of US$0.045 per share

Shareholders Can Be Confident That LifeVantage's (NASDAQ:LFVN) Earnings Are High Quality

Third quarter dividend increased to US$0.045

New major risk - Revenue and earnings growth

Third quarter 2025 earnings: EPS exceeds analyst expectations while revenues lag behind

LifeVantage Corporation Declares Cash Dividend, Payable on June 13, 2025

What You Can Learn From LifeVantage Corporation's (NASDAQ:LFVN) P/E After Its 26% Share Price Crash

LifeVantage Corporation to Report Q3, 2025 Results on May 06, 2025

Chief Marketing Officer exercised options and sold US$58k worth of stock

LifeVantage Corporation Expands Global Reach with International Launch of the Mb System

Upcoming dividend of US$0.04 per share

Independent Chairman of the Board recently sold US$161k worth of stock

New Initiatives Will Drive MindBody GLP-1 System's Future Success

Consensus EPS estimates fall by 20%

Independent Chairman of the Board notifies of intention to sell stock

LifeVantage (NASDAQ:LFVN) Will Pay A Dividend Of $0.04

Second quarter dividend of US$0.04 announced

LifeVantage Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Second quarter 2025 earnings: EPS exceeds analyst expectations

LifeVantage: Post-Earnings Sell-Off Provides Buying Opportunity

LifeVantage Corporation Announces Quarterly Dividend, Payable on March 17, 2025

LifeVantage Corporation (NASDAQ:LFVN) Looks Just Right With A 33% Price Jump

LifeVantage Corporation Announces Completion of International In Vitro Study on the MB System

What Is LifeVantage Corporation's (NASDAQ:LFVN) Share Price Doing?

Investor sentiment deteriorates as stock falls 15%

LifeVantage Corporation to Report Q2, 2025 Results on Feb 05, 2025

Lifevantage Study Confirms Breakthrough Synergistic Effects of Healthy Weight Stack

Investor sentiment improves as stock rises 27%

LifeVantage Corporation Raises Revenue Guidance for the Fiscal Year 2025

New minor risk - Share price stability

Chief Marketing Officer exercised options and sold US$54k worth of stock

Market Participants Recognise LifeVantage Corporation's (NASDAQ:LFVN) Earnings Pushing Shares 31% Higher

Investor sentiment improves as stock rises 15%

LifeVantage (NASDAQ:LFVN) Will Be Hoping To Turn Its Returns On Capital Around

Lifevantage Unveils Lip Care Favorite Back for Cyber Monday

Upcoming dividend of US$0.04 per share

LifeVantage's (NASDAQ:LFVN) Dividend Will Be $0.04

LifeVantage's (NASDAQ:LFVN) Dividend Will Be $0.04

First quarter dividend of US$0.04 announced

First quarter 2025 earnings released: EPS: US$0.15 (vs US$0.05 in 1Q 2024)

LifeVantage Corporation Announces Groundbreaking Results from A Human Clinical Trial Performed on the New MindBody GLP-1 System

Investor sentiment improves as stock rises 15%